RegWardenFDA facility compliance records
Facility

Vantive US Healthcare LLC

3 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2025: 2 recalls; 2026: 1 recalls201720182019202020212022202320242202512026
  • Recalls (3)

Devices registered here (1)

  • Subsystem, Water Purification
    Product code FIP (opens in a new tab) · Class II · Gastroenterology, Urology · 21 CFR 876.5665

Recalls & enforcement

  • Class IIOngoing2026-01-06
    There is a potential dislodgement of the Prismaflex Set deaeration chamber from the Prismaflex Control Unit.
  • Class IIOngoing2025-08-28
    Vantive has identified a software defect within the Sharesource Claria software, which may cause a patient s updated prescription program settings to not be properly saved on the actual cycler that the patient is using to perform their therapy. As a result, the clinician may thin…
  • Class IIOngoing2025-07-28
    Thermax System may be unable to detect the presence of a bag on the Thermax Blood Warmer Unit leading to difficulty setting up therapy, or PrisMax System alarm T2284: Thermax Disposable Not Inserted

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Vantive US Healthcare LLC (FEI 3038195011) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3038195011-vantive-us-healthcare-llc/

Not open yet

Alerts for Vantive US Healthcare LLC

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.